| Date Filed | Type | Description |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/12/2021 |
4
| Albanna Rowena (COO) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 50,000 restricted stock units
@ $0
Granted 50,000 restricted stock units
@ $0 |
|
| 11/12/2021 |
4
| Shabahang Shahrokh (Chief Innovation Officer) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 55,000 restricted stock units
@ $0
Granted 50,000 restricted stock units
@ $0 |
|
| 11/12/2021 |
4
| Farley Thomas J (CFO) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 60,000 restricted stock units
@ $0
Granted 95,000 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Chung Lauren (Director) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 2,500 restricted stock units
@ $0
Granted 11,500 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Kiaie Namvar (Director) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 11,500 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Brady Brian Michael (Director) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 11,500 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| ANTHONY LAURA E (Director) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 11,500 restricted stock units
@ $0 |
|
| 10/01/2021 |
4
| Runge Jeffrey W. (Director) has filed a Form 4 on Aditxt, Inc.|
Txns:
| Granted 11,500 restricted stock units
@ $0 |
|
| 06/23/2021 |
3
| Chung Lauren (Director) has filed a Form 3 on Aditx Therapeutics, Inc. |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Albanna Rowena (COO) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Shabahang Shahrokh (CHIEF INNOVATION OFFICER) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Bought 490 shares
@ $2.93, valued at
$1.4k
|
|
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Albanna Rowena (COO) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Bought 500 shares
@ $2.93, valued at
$1.5k
Bought 1,000 shares
@ $2.95, valued at
$3k
Bought 800 shares
@ $2.9, valued at
$2.3k
Bought 100 shares
@ $2.89, valued at
$289 |
|
| 05/28/2021 |
4
| Shabahang Shahrokh (CHIEF INNOVATION OFFICER) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Bought 279 shares
@ $2.4, valued at
$669.6
Bought 138 shares
@ $2.38, valued at
$328.4
Bought 185 shares
@ $2.7, valued at
$499.5 |
|
| 05/27/2021 |
4
| Farley Thomas J (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Bought 2,500 shares
@ $2.6799, valued at
$6.7k
|
|
| 05/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2021 |
3
| Farley Thomas J (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 3 on Aditx Therapeutics, Inc. |
| 03/22/2021 |
4
| Shabahang Shahrokh (CHIEF INNOVATION OFFICER) has filed a Form 4 on Aditx Therapeutics, Inc.|
Txns:
| Exercised (out-of-the-money) 18,750 warrants
@ $4, valued at
$75k
|
|
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2020 |
4
| Pankovcin Corinne (CFO) has filed a Form 4 on ADiTx Therapeutics, Inc.|
Txns:
| Granted 15,000 options to buy
@ $1.92, valued at
$28.8k
Granted 165,000 options to buy
@ $1.92, valued at
$316.8k
|
|
| 11/04/2020 |
4
| Shabahang Shahrokh (CHIEF INNOVATION OFFICER) has filed a Form 4 on ADiTx Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $1.92, valued at
$211.2k
|
|
| 11/04/2020 |
4
| Albanna Rowena (COO) has filed a Form 4 on ADiTx Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.92, valued at
$192k
|
|
| 11/04/2020 |
4
| Albanna Amro A. (CEO) has filed a Form 4 on ADiTx Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.92, valued at
$192k
|
|
| 10/16/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/16/2020 |
4/A
| ANTHONY LAURA E (Director) has filed a Form 4 on ADiTx Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $1.94, valued at
$19.4k
|
|
| 10/16/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/16/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|